Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov-Dec;4(6):1089-1100.
doi: 10.1016/j.jaip.2016.08.004.

Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies

Jolan E Walter  1 , Jocelyn R Farmer  2 , Zsofia Foldvari  3 , Troy R Torgerson  4 , Megan A Cooper  5
Affiliations
Review

Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies

Jolan E Walter et al. J Allergy Clin Immunol Pract. 2016 Nov-Dec.

Abstract

A broad spectrum of autoimmunity is now well described in patients with primary immunodeficiencies (PIDs). Management of autoimmune disease in the background of PID is particularly challenging given the seemingly discordant goals of immune support and immune suppression. Our growing ability to define the molecular underpinnings of immune dysregulation has facilitated novel targeted therapeutics. This review focuses on mechanism-based treatment strategies for the most common autoimmune and inflammatory complications of PID including autoimmune cytopenias, rheumatologic disease, and gastrointestinal disease. We aim to provide guidance regarding the rational use of these agents in the complex PID patient population.

Keywords: Arthritis; Autoimmune enteropathy (AIE); Autoimmunity; Cytopenias; Inflammatory bowel disease (IBD); Lupus; Primary immunodeficiencies (PIDs); Treatment; Vasculitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms of targeting B cell pathology in the treatment of autoimmune and inflammatory diseases associated with PID.
See this image and copyright information in PMC

References

    1. Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726. - PMC - PubMed
    1. Allenspach E, Torgerson TR. Autoimmunity and Primary Immunodeficiency Disorders. J Clin Immunol. 2016 - PubMed
    1. Maggadottir SM, Sullivan KE. The intersection of immune deficiency and autoimmunity. Curr Opin Rheumatol. 2014;26(5):570–8. - PubMed
    1. Grimbacher B, Warnatz K, Yong PF, Korganow AS, Peter HH. The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects. J Allergy Clin Immunol. 2016;137(1):3–17. quiz 8. - PubMed
    1. Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, et al. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica. 2011;96(5):655–63. - PMC - PubMed

Publication types

MeSH terms